Holen Sie sich die Stockscreener-App
27.24
5.02%
-1.44
Schlusskurs vom Vortag:
$28.68
Offen:
$28.71
24-Stunden-Volumen:
521.90K
Relative Volume:
1.73
Marktkapitalisierung:
$1.62B
Einnahmen:
$83.72M
Nettoeinkommen (Verlust:
$-143.89M
KGV:
-9.6843
EPS:
-2.8128
Netto-Cashflow:
$-120.48M
1W Leistung:
+0.96%
1M Leistung:
+13.12%
6M Leistung:
+33.46%
1J Leistung:
+17.06%
1-Tages-Spanne:
$26.99
$29.01
1-Wochen-Bereich:
$25.39
$29.01
52-Wochen-Spanne:
$17.34
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
27.24 | 1.62B | 83.72M | -143.89M | -120.48M | -2.8128 |
ISRG
Intuitive Surgical Inc
|
426.70 | 150.74B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
191.75 | 52.23B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
238.97 | 33.61B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.18 | 31.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.96 | 31.55B | 29.14B | 1.07B | 1.05B | 1.1956 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-10 | Eingeleitet | JP Morgan | Overweight |
| 2026-07-21 | Eingeleitet | Oppenheimer | Perform |
| 2025-11-18 | Eingeleitet | BTIG Research | Buy |
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Kestra Medical Technologies director sells $97,504 in shares By Investing.com - Investing.com South Africa
Kestra Medical Technologies director sells $97,504 in shares By Investing.com - Investing.com Australia
Kestra Medical Technologies director sells $97,504 in shares - Investing.com
Kestra Medical Technologies director sells $97,504 in shares - Investing.com India
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com - Investing.com Nigeria
To cover vesting taxes, Kestra Medical (KMTS) director sells 3,330 shares. - Stock Titan
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com - Investing.com Australia
Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies - Yahoo Finance
Only 30 of 100 honorees earned five stars. Kestra was the only one in the medical equipment manufacturing category. - Stock Titan
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com - Investing.com Canada
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com - Investing.com India
A 3,330-share sale is proposed by officer Raymond Cohen of Kestra Medical (Nasdaq: KMTS). - Stock Titan
Kestra Medical director Elizabeth Kwo sells $97,267 in shares By Investing.com - Investing.com Nigeria
To cover taxes on vested stock awards, a Kestra Medical (KMTS) director sold 4,010 shares. - Stock Titan
Kestra Medical (KMTS) executive plans $97K stock sale - Stock Titan
Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Othe - Benzinga
Kestra Medical Technologies (NasdaqGS:KMTS) Stock Forecast & Analyst Predictions - Simply Wall Street
Kestra Medical (KMTS) sees revenue surge while losses deepen - Stock Titan
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results - GlobeNewswire
Kestra Medical Technologies Ltd (KMTS) Q1 2027 Earnings Report P - GuruFocus
Kestra Medical Technologies Ltd (KMTS) Q1 2027 Earnings Report Preview: What To Look For - Yahoo Finance
KMTS Q1'26 Earnings: EPS estimate is (0.62) USD - TradingView
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Kestra Medical’s Schwartz sells $97,942 in stock for tax obligations By Investing.com - Investing.com Australia
Kestra Medical’s Schwartz sells $97,942 in stock for tax obligations By Investing.com - Investing.com South Africa
Kestra Medical director Conor Hanley sells $143,778 in shares By Investing.com - Investing.com South Africa
Kestra Medical director Conor Hanley sells $143,778 in shares By Investing.com - Investing.com South Africa
Kestra Medical director Conor Hanley sells $143,778 in shares By Investing.com - Investing.com Australia
Kestra Medical’s Schwartz sells $97,942 in stock for tax obligations By Investing.com - Investing.com Nigeria
Kestra Medical director Conor Hanley sells $143,778 in shares By Investing.com - Investing.com Canada
Kestra Medical director Conor Hanley sells $143,778 in shares By Investing.com - Investing.com India
Kestra Medical director Conor Hanley sells $143,778 in shares - investing.com
Kestra Medical’s Schwartz sells $97,942 in stock for tax obligations - Investing.com
Kestra Medical director Kevin Reilly sells $73,677 in shares By Investing.com - Investing.com Australia
Director's tax share sale and 25 million-share stake at Kestra Medical (KMTS) - Stock Titan
Kestra Medical director Kevin Reilly sells $73,677 in shares - Investing.com
Kestra Medical director Kevin Reilly sells $73,677 in shares - investing.com
Kestra Medical Technologies director Ladone sells $98,464 of KMTS stock - investing.com
[Form 4] KESTRA MEDICAL TECHNOLOGIES, LTD. Insider Trading Activity - Stock Titan
Director at Kestra Medical (KMTS) sells shares to cover taxes after new RSU grant - Stock Titan
Director at Kestra Medical (KMTS) now holds 18,126 shares after RSU grant - Stock Titan
Director at Kestra Medical Technologies (KMTS) sells shares in tax sell-to-cover trade - Stock Titan
94% of Kestra Medical (KMTS) shares vote on board and auditor - Stock Titan
Kestra Medical names Daniel Finney VP of research & development - investing.com
Kestra Medical Technologies Appoints Daniel Finney as Vice President of Research & Development - Quiver Quantitative
The developer of a wearable heart device will lead Kestra's research - Stock Titan
Kestra Medical Technologies director Ladone sells $98,464 of KMTS stock - Investing.com
Kestra Medical director Conor Hanley sells $143,778 in shares - Investing.com
Tax-withholding share sale and new stock grant at Kestra Medical (KMTS) - Stock Titan
KMTS: Director elections and auditor ratification passed; no shareholder questions were received - TradingView
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kestra Medical Technologies Ltd-Aktie (KMTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| COHEN RAYMOND W | Officer |
Sep 30 '26 |
Proposed Sale |
29.28 |
3,330 |
97,504 |
0 |
| Kwo Elizabeth | Director |
Sep 21 '26 |
Sale |
24.26 |
4,010 |
97,268 |
14,116 |
| Kwo Elizabeth | Officer |
Sep 21 '26 |
Proposed Sale |
24.26 |
4,010 |
97,268 |
0 |
| Reilly Kevin C | Director |
Sep 08 '26 |
Sale |
25.13 |
2,932 |
73,677 |
5,368 |
| Ladone Mary Kay | Officer |
Sep 08 '26 |
Proposed Sale |
25.20 |
3,908 |
98,464 |
0 |
| Schwartz Jeffrey Lawrence | Director |
Sep 08 '26 |
Sale |
25.18 |
3,890 |
97,942 |
7,019 |
| Reilly Kevin C | Officer |
Sep 08 '26 |
Proposed Sale |
25.13 |
2,932 |
73,677 |
0 |
| Hanley Conor | Officer |
Sep 08 '26 |
Proposed Sale |
25.25 |
5,694 |
143,778 |
0 |
| Ladone Mary Kay | Director |
Sep 08 '26 |
Sale |
25.20 |
3,908 |
98,464 |
37,507 |
| Jeffrey Lawrence Schwartz | Director |
Sep 08 '26 |
Proposed Sale |
25.18 |
3,890 |
97,944 |
0 |
2.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):